Contraindications for Mounjaro: Knowing When It Isn't the Right Fit

The hard stops: conditions where Mounjaro cannot be used

Two contraindications are absolute under the Mounjaro SmPC. The first is a personal or family history of medullary thyroid carcinoma. Tirzepatide (like all GLP-1 medicines) has shown thyroid C-cell changes in rodent studies; the relevance to humans is not fully established, but for anyone with MTC or a close family history of it, the risk cannot be ruled out and the medicine should not be prescribed. The second absolute contraindication is Multiple Endocrine Neoplasia syndrome type 2 (MEN2), a hereditary condition that itself strongly predisposes to MTC.

These aren't common, but they're worth knowing. A quick check of your own and your immediate family's medical history (something most people can do in under a minute) will tell you whether either applies before you reach the consultation stage.

Beyond these two, the current approved indication matters: Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. Being outside those criteria isn't strictly a contraindication, but it does mean a prescriber is unlikely to approve treatment. You can read more about who Mounjaro is licensed for in the UK if you want the full eligibility picture before your consultation.

Pregnancy, breastfeeding and planning a family

Mounjaro is not recommended during pregnancy, during breastfeeding, or when someone is actively trying to conceive. The medicine has not been studied adequately in pregnant people, and until that evidence exists it is considered unsafe to use. This isn't a regulatory technicality, it reflects genuine uncertainty about fetal safety that a responsible prescriber will not overlook.

There is a specific practical point here for anyone using oral contraceptives alongside Mounjaro. Because tirzepatide slows gastric emptying, absorption of the contraceptive pill may be reduced during the first weeks of treatment and after each dose increase. NHS guidance advises adding a non-oral method of contraception (for example condoms) for the first four weeks of starting Mounjaro and for four weeks after every upward dose step. This isn't the same as stopping the pill, but it does require planning, and your prescriber should discuss it at assessment. For anyone on HRT, NHS England suggests considering transdermal formulations (patches or gels) for the same absorption reason, and this too is worth raising before treatment begins.

Under-18s are excluded from the licensed indication entirely. There is no approved dose, no established safety profile and no trial data for this age group in the context of weight management.

Conditions that need careful clinical weighing, not an automatic no

Several medical histories don't automatically rule out Mounjaro but do require honest disclosure and careful assessment. A history of pancreatitis sits at the top of this list. The MHRA issued a Drug Safety Update in January 2026 confirming that acute pancreatitis is a known, if infrequent, side effect of GLP-1 medicines including tirzepatide. For anyone who has had pancreatitis before, the prescriber needs to weigh whether treatment is appropriate, and patients on treatment should know to seek urgent medical help for severe, persistent abdominal pain that spreads to the back, with or without vomiting.

Serious gastrointestinal conditions (including gastroparesis or severe inflammatory bowel disease) can interact unpredictably with a medicine that slows gastric emptying as part of its mechanism. Severe kidney disease (including end-stage renal failure) and serious liver disease are also factors that warrant prescriber discussion, not because they are listed as hard contraindications in every case, but because the safety data in these groups is limited.

A careful look at your current medication list matters too. Oral medicines that depend on reliable absorption timing (including some anticoagulants and some hormone preparations) may be affected. This is one reason the guidance on how Mounjaro is taken is worth reading before a consultation, so the questions you raise are specific and useful. The NHS's information on tirzepatide, available on the NHS medicines page for tirzepatide, covers known interactions in accessible language.

How a prescriber works through this, and what it means for your consultation

This is where a decision-led approach becomes genuinely useful. The contraindications for Mounjaro aren't a checklist you tick through alone, they are the starting point for a clinical conversation. A GPhC-registered Independent Prescriber at a regulated pharmacy will review your medical history, your current medicines, your BMI and your weight-related conditions as a whole before a prescription is issued. At nume, that review happens on the same day you submit your consultation; it is a real clinician reading your answers, not a form-processing system.

If something in your history sits in the grey zone (a resolved episode of pancreatitis years ago, a current medication with uncertain interactions, or questions around your contraception) the right outcome isn't a hurried approval. It's a conversation that reaches an answer you can trust. If Mounjaro turns out not to be appropriate, other options exist; the weight-loss treatment overview covers the licensed alternatives, and our prescribers can advise on which, if any, would be suitable for your situation.

For a full picture of eligibility criteria alongside contraindications, the qualifications required for a Mounjaro prescription page goes into the BMI and comorbidity thresholds in detail. And if you'd like to understand how our clinical team approaches these decisions, our prescribing lead's profile sets out the standard we hold ourselves to. Cost is a reasonable question too, and if you're looking to reduce what you pay, our page on finding a promotion code for Mounjaro explains what legitimate discounts are available and how to apply them. Once treatment begins, supporting your body through the adjustment period is also worth thinking about, and our guide to the best electrolytes to take alongside Mounjaro covers why hydration and mineral balance matter during treatment. How Mounjaro pricing compares across UK providers explains what a legitimate private prescription includes, which bears on the safety argument directly.

If, after reading through the above, you think Mounjaro may be suitable for you, the next step is a free consultation with our prescribers, reviewed the same day, with no obligation until a prescription is confirmed as clinically appropriate. Speak to our prescribers to get started.